Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
8.92
+0.77 (9.45%)
At close: Feb 6, 2026, 4:00 PM EST
8.88
-0.04 (-0.47%)
After-hours: Feb 6, 2026, 7:59 PM EST
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $1.55 billion as of February 6, 2026. Its market cap has increased by 88.89% in one year.
Market Cap
1.55B
Enterprise Value
982.93M
1-Year Change
88.89%
Ranking
Category
Stock Price
$8.92
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $1.55B, a decrease of -49.06%. That is a compound annual growth rate of -11.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 1.55B | 5.44% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 1.56B |
| Upstream Bio | 1.55B |
| Trevi Therapeutics | 1.47B |
| Fortrea Holdings | 1.47B |
| Biohaven | 1.46B |
| Intellia Therapeutics | 1.45B |
| Kodiak Sciences | 1.44B |
| DBV Technologies | 1.37B |